All Pharma News
Lilly`s Prevail walks away from Precision gene editing collab

Lilly`s Prevail walks away from Precision gene editing collab
James Waldron FIERCE BIOTECH
17 Apr 2024
Share Share
Lilly taps Sangamo to explore AAV capsids for neurological targets

Lilly taps Sangamo to explore AAV capsids for neurological targets
PRESS RELEASE
18 Jul 2023
Share Share
Lilly`s Prevail drops deal value for Precision gene therapy pact

Lilly`s Prevail drops deal value for Precision gene therapy pact
Gabrielle Masson FIERCE BIOTECH
07 Jul 2023
Share Share
Scribe`s CRISPR tech Prevails with new $1.5B Lilly biobucks deal

Scribe`s CRISPR tech Prevails with new $1.5B Lilly biobucks deal
Gabrielle Masson FIERCE BIOTECH
17 May 2023
Share Share
Prevail, Capsida partner to develop gene therapies for nervous system diseases

Prevail, Capsida partner to develop gene therapies for nervous system diseases
Delilah Alvarado BIOPHARMADIVE
05 Jan 2023
Share Share
Lacerta & Prevail, Sign Agreement to Develop Novel AAV Capsids for CNS Disorders

Lacerta & Prevail, Sign Agreement to Develop Novel AAV Capsids for CNS Disorders
BUSINESSWIRE
23 Aug 2022
Share Share
Lilly to create $700mn Institute for Genetic Medicine

Lilly to create $700mn Institute for Genetic Medicine
EUROPEANPHARMACEUTICALREVIEW
23 Feb 2022
Share Share
Asa Abeliovich and OrbiMed are teaming on yet another biotech

Asa Abeliovich and OrbiMed are teaming on yet another biotech
Jason Mast ENDPTS
14 Feb 2022
Share Share
Lilly Completes Acquisition of Prevail Therapeutics

Lilly Completes Acquisition of Prevail Therapeutics
PRNEWSWIRE
22 Jan 2021
Share Share
Lilly Acquires Prevail and Gene Therapy for Neuronopathic Gaucher

Lilly Acquires Prevail and Gene Therapy for Neuronopathic Gaucher
GAUCHERDISEASENEWS
21 Dec 2020
Share Share